Plasma Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) as a Possible Biomarker for Severe COVID-19

Plasma Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) as a Possible Biomarker for Severe COVID-19

Proprotein convertase subtilisin/kexin type 9 (PCSK9) reduces low density lipoprotein (LDL) uptake, leading to increased plasma levels of LDL. In addition, PCSK9 has been implicated in inflammation independently of the effects on cholesterol metabolism. The current analysis showed that our 156 patie...

Full description

Bibliographic Details
Main Authors: Patricia Mester, Pablo Amend, Stephan Schmid, Martina Müller, Christa Buechler, Vlad Pavel
Format: Article
Language:English
Published: MDPI AG 2023-07-01
Series:Viruses
Subjects:
COVID-19
ventilation
procalcitonin
survival
Online Access:https://www.mdpi.com/1999-4915/15/7/1511

Similar Items

Similar Items